FDA Drug recall D-1413-2020
Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08
- FDA Drug
- Class II
- terminated
- Published 2020-08-05
On 2020-08-05 the FDA classified a Class II recall of Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08 by Lupin Pharmaceuticals, citing presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1413-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-07-17 |
| Published | 2020-08-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08
Reason
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
Identifiers
| ndc | 68001-337-00 |
|---|---|
| ndc | 68001-337-08 |
| ndc | 68001-332-00 |
| ndc | 68001-332-03 |
| ndc | 68001-333-00 |
| ndc | 68001-333-08 |
| ndc | 68001-486-00 |
| ndc | 68001-486-08 |
| ndc | 68001-334-00 |
| ndc | 68001-334-08 |
| ndc | 68001-335-00 |
| ndc | 68001-335-08 |
| ndc | 68001-336-00 |
| code_info | Lot # Q000232, exp. date 01/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1413-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.